Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

1990 • 1,163 citations

Confidence Intervals for Reporting Results of Clinical Trials

1986 • 425 citations

Chemotherapy of non-small-cell lung cancer.

1985 • 148 citations

New folate analogs of the 10-deaza-aminopterin series Basis for structural design and biochemical and pharmacologic properties

1984 • 143 citations

New folate analogs of the 10-deaza-aminopterin series

1984 • 138 citations

Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare

1988 • 129 citations

Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future

1983 • 121 citations

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

1988 • 79 citations

New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.

1985 • 69 citations

Synthesis and antitumor activity of 10-alkyl-10-deazaminopterins. A convenient synthesis of 10-deazaminopterin

1982 • 48 citations

New agents in non-small cell lung cancer

1984 • 44 citations

Chemotherapy in advanced non-small cell lung cancer

1990 • 42 citations

Toxic dermatitis induced by 10-ethyl-10-deazaaminopterin (10-EdAM), a novel antifolate

1990 • 10 citations

Pharmacokinetics of 10-ethyl-10-deaza-aminopterin, edatrexate, given weekly for non-small-cell lung cancer

1993 • 4 citations